Navigation Links
Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification

SALT LAKE CITY, UT, June 11, 2007 (MARKET WIRE via COMTEX News Network) -- Myriad Genetics, Inc. (NASDAQ: MYGN) (www.myriad.com) announced today that it presented a mathematical comparison of a "Staggered Start" and a "Randomized Withdrawal" clinical trial design with a "Natural History Staggered Start" clinical trial design at the Alzheimer's Association Prevention Conference held June 9 - 12, 2007, in Washington, D.C. The analysis demonstrates that the "Natural History Staggered Start" trial design currently being used in the Flurizan Phase 3 study can provide the same level of disease modification support as the cross-over trial designs, which are challenged by ethical concerns, dropout bias and complications.

A disease modifying therapy for Alzheimer's disease (AD) is one that has an impact on the underlying pathology of the disease and thus slows the rate of a patient's decline over the course of long-term treatment. In contrast, the currently available AD medicines are believed to treat the symptoms of AD without impacting the underlying disease process or providing long lasting benefit. The development of robust methods to demonstrate disease modification in AD clinical trials has been a controversial issue in the field, and to date, there have been no studies that provide convincing evidence of disease modification in AD. Two clinical trial designs that could provide evidence for disease modification were originally proposed for AD studies over 10 years ago by Paul Leber, then the head of the Division of Neuropharmacological Drug Products of the FDA. These designs have come to be known as the "Randomized Withdrawal" and "Staggered Start" designs and are based on measuring clinical outcomes in a cross-over type study.

In the randomized withdrawal design, patients are withdrawn from therapy after a defined period to determine whethe
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Myriad Genetics Presents Tumor Origin Technology at AACR
2. Myriad Genetics Presents Azixas Mode of Action at AACR
3. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
4. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
5. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
6. ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
7. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
8. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
9. Expression Genetics, Inc. Announces Successful Completion of Phase I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer
10. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
11. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
Post Your Comments:
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... today lauded the latest results achieved by the ... known as the National Precursor Log Exchange (NPLEx), ... enforcement officials track down methamphetamine offenders and make ... in Michigan blocked the ...
(Date:8/20/2014)... YORK , Aug. 20, 2014 ... is available in its catalogue: The ... IVD Industry http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html ... Act" (H.R. 3590) is complex legislation that affects ... of its provisions are beginning to take effect ...
(Date:8/20/2014)... , Aug. 20, 2014 Torrance ... be using advanced, ventilator technology from Covidien to ... care for patients. The acute ... naturally, compared to conventional mechanical ventilation, and help ... as possible. Patients on mechanical ventilation are often ...
Breaking Medicine Technology:Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Torrance Memorial Medical Center Acquires Advanced Ventilator Technology to Enhance Patient Care 2
(Date:8/21/2014)... 2014 mynt welcomes industry leaders Rob ... join its growing company. Since its pre-launch in April, ... sales and continues to gain momentum leading up to ... and Tiffanie came into network marketing by chance. Tiffanie ... of network marketing companies. Tiffanie needed help at one ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 According ... by Application (Biodegradable polymer, Food & Beverage, Personal ... Application (Packaging, Agriculture, Automobile, Electronics, Textile) & Geography ... the lactic acid and polylactic acid markets and ... of each market, based on their sub-segments, in ...
(Date:8/21/2014)... San Luis Obispo, CA (PRWEB) August 21, 2014 ... July/August edition of Current Pedorthics, a bi-monthly publication of the ... the field of pedorthics. , Bunion Bootie ... as an alternative solution for bunion sufferers and their pain. ... be worn in nearly any shoe to eliminate the friction ...
(Date:8/21/2014)... 2014 While golfing in Scotland and ... to stay focused on his game due to the ... whine, slapping and continual need to spray insect repellent ... stay protected from insects while golfing. He ultimately found ... Financial Services/Investment Banking Industry, decided to change direction and ...
(Date:8/21/2014)... August 21, 2014 Atlantic Information Services, ... ACO Business News and The AIS Report on Blue ... Blue Cross Blue Shield Association or its member companies) ... latest report in AIS’s Management Insight Series. Bundled ... studies of two insurers — Horizon Healthcare Services, Inc. ...
Breaking Medicine News(10 mins):Health News:Industry Leaders Rob and Tiffanie Moffitt Join mynt 2Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 2Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 3Health News:Recently Featured in Current Pedorthics: Bunion Bootie, the Very Popular Bunion Treatment Splint 2Health News:Recently Featured in Current Pedorthics: Bunion Bootie, the Very Popular Bunion Treatment Splint 3Health News:Financial VP Fights Pesky Bugs with Launch of Biteback Sports Insect Shield® Golf Apparel 2Health News:New AIS Report Highlights Two Case Studies of Bundled Payment Models 2
... , - Tobacco use is the single most preventable cause of death ... 400,000 Americans die each year from tobacco-related disease , ... , illegal drugs, car crashes, fires, murders, and suicides combined. ... seconds . , , HOUSTON, June 23 DaretoQuit.com is ...
... earlier this month by Harvard Law School, Harvard Medical ... bills are involved in more than 60 percent of US ... more than 75 percent of these families reported having health ... wake of these startling increases and the current recession, The ...
... At Risk with Atlantic Hurricane Predictions; Are Their Medical Records ... With hurricane season upon us, more than 35 million Americans ... their medical records. According to the National Ocean and ... having nine to 14 named storms, of which four to ...
... ... provides up to 99% accuracy right out of the box. The Nuance Dragon Medical 10.1 ... the ideal chance for existing Dragon Medical users to upgrade and become even more efficient. ... Austin, Texas (PRWEB) June ...
... June 23 /PRNewswire-Asia/ -- Wan (Corporate Services) Ltd., the,sole agent of Perrier ... level of Perrier. , ... We strongly believe the Consumer Council Findings is not correct. ... mg/L of Nitrite in Perrier is,not correct. , ...
... tumor growth , MONDAY, June 22 (HealthDay News) -- A ... of cancer and could potentially be harnessed as a cancer ... for inhibiting or treating metastasis -- the migration of cancer ... the body. Metastasis is one of the leading causes of ...
Cached Medicine News:Health News:STOP SMOKING ONLINE: Houston Psychologists Develop Groundbreaking, Interactive Stop Smoking Program 2Health News:The Wellness Community Launches National Education Program Addressing the Cost of Cancer Care 2Health News:The Wellness Community Launches National Education Program Addressing the Cost of Cancer Care 3Health News:Consumers Encouraged to Add Personal Health Records (PHR) to Hurricane Preparedness Checklist 2Health News:Consumers Encouraged to Add Personal Health Records (PHR) to Hurricane Preparedness Checklist 3Health News:The New Dragon Medical 10.1 is Now Available 2Health News:The New Dragon Medical 10.1 is Now Available 3Health News:Perrier Clarifies the NITRITE Level in Consumer Council Findings 2Health News:Lab Study Finds Protein That May Inhibit Cancer Spread 2
... the parafollicular C-cells of the thyroid gland ... major action of calcitonin is to lower ... resulting in decreased mobilization of calcium from ... in conditions associated with high levels of ...
Validated by decades of research and clinical experience, HFA is the accepted standard of care in glaucoma diagnosis and management. With HFA you can feel confident you're providing the best possible...
Erbium Laser with Sapphire Erbium Handpiece for Dermatological and Cosmetic Surgery...
... The Bio-Optics LSM-12000 is a new High ... new tool in anterior segment diagnostics and ... to operate, easy to maintain, and very ... the only High Magnification Slit-Lamp Biomicroscope available ...
Medicine Products: